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Rabies postexposure prophylaxis (PEP) is
expensive, not totally free of risk, and overused
(1).  A national public health objective for the year
2000 is to reduce the number of prophylaxis
treatments by 50% (2). In Kentucky, where PEP
is administered in public and private settings,
there are no baseline data on PEP use.
A survey of local health departments was
used to determine the nature of each patient’s
exposure to rabies. The number of PEP treat-
ments administered by all providers in Kentucky
was estimated from local health department
information on rabies biologics purchases and use.
Survey and Sales Summary
In May 1995, the 1994 invoices of the
Kentucky Department for Health Services,
Vaccine Depot, were reviewed to determine
which local health departments received 1.0 ml
doses of human diploid cell vaccine for PEP.
(Local health departments used 1.0 ml human
diploid cell vaccine for PEP only, and 0.1 ml
human diploid cell vaccine intradermally for all
rabies preexposure prophylaxis). Data from two
large health departments that acquired their
vaccine directly from the manufacturer rather
than from the Vaccine Depot were included in the
survey. In June 1995, local health departments
that had administered at least one PEP during
1994 were asked to review the records of patients
receiving PEP. Information (patient’s age and
sex, the number of doses of human diploid cell
vaccine, whether human rabies immune globulin
was administered, exposure information, and
method of payment for the treatment) collected
on each patient was recorded on a standardized
form by the same telephone surveyor during a
follow-up telephone call. All data were entered
into an Epi Info Version 5.0 record file and
analyzed in either the Analysis or Statcalc Pro-
grams for summary statistics and/or odds ratios,
confidence intervals, Fisher’s exact test, or Chi-
square at the .05 significance level (3).
A sales record summary for human diploid
cell vaccine sold to all providers in Kentucky was
obtained from the only manufacturer of human
rabies vaccine recording any sales in Kentucky
that year (Connaught Laboratories, Inc., Swift-
water, PA). The number of PEPs administered in
the state by all providers was estimated by
comparing local health department purchases
and use with the total number of human diploid
cell vaccine 1.0 ml doses sold to other providers
with Kentucky addresses.
PEP Administration Profile
Vaccine Depot records indicated that 28 health
departments treated a total of 97 patients. The
number of PEP regimens administered per health
department ranged from 1 to 23 with a median of
1 PEP for the year. Fifty-two (53.6%) of the
patients were male (Table 1); the median age was
28 years (range 2 to 71); 34 (35.1%) patients were
younger than 18 years of age; 59 (60.8%) were
older than 18 years of age; and for 4 (4.1%), age
was unknown. No significant differences were
observed in the type of animal exposure by sex
or age.  Seven patients (7.2%) had previously
received PEP and were treated with two to
three doses of human diploid cell vaccine and
no human rabies immune globulin.
Urban health departments (in the three
metropolitan statistical areas of the state) were
more likely to administer PEP than rural health
departments (odds ratio = 1.54, confidence inter-
val = 1.01, 2.33) (4). Patients did not significantly
Rabies Postexposure Prophylaxis
Survey—Kentucky, 1994
A survey of rabies postexposure prophylaxis administered by local health
departments for a 1-year period showed that very few patients received treatment as a
result of exposure to a confirmed rabid animal. Most prophylaxis was administered for
contact with domestic animals in situations where existing recommendations for
quarantine or laboratory testing of the animal were not followed. Because rabies in
domestic animals in Kentucky is uncommon, these findings suggest that had the
existing recommendations been followed, the prophylaxis would have been
unnecessary in most cases.200 Emerging Infectious Diseases Vol. 3, No. 2, April–June 1997
Dispatches
differ in age, sex, or type of exposure between
urban and rural health departments.
For 25 (25.8%) of the patients, local health
department funds covered the expense of PEP
treatments; no payment was received from pri-
vate insurance, Medicaid, Medicare, or the patient.
There were no significant differences in payment
characteristics between urban and rural health
department patients.
Bite exposures were responsible for 71 (73.2%)
of the 97 PEP treatments, 18 (18.6%) exposures
were scratches, licks, or “other,” and 8 (8.2%) expo-
sure types were not recorded. Domestic animals
accounted for 80 (82.5%) of the exposures treated.
Type of Animal Exposure
Sixty-four (77.1%) of 83 animals involved in
these incidents were not available for observation
or testing. For wild animals, testing was per-
formed in 3 (20%) of 15 incidents. Testing or
observation occurred in only 16 (20.0%) of 80
domestic animal exposures.
Stray domestic animals accounted for 26
(26.8%) of all exposures. Another 19 (19.6%) of
the incidents involved owned dogs that were
unavailable for testing or observation. Una-
vailability for testing was due to severe brain
damage caused by clubbing or gunshot by irate
owners, death and disposal of the animal without
testing, or the animal’s escape. For 36 (37%)
incidents, the reason for not testing or observing
the animal was not specified.
Thirteen (13.4%) of the patients were
exposed to an animal that was tested and found
to be positive for rabies, and two of these patients
had bite exposures. The remaining exposures to
these rabies-positive animals were either low-
risk exposures or not true exposures (Table 2).
Table 1. Characteristics of local health department




Unspecified   2
Agea Youth (2 - 10) 19
Adolescent (11 - 17) 15
Adult (18-71) 59




Previously immunized   6
Animal exposure
Wild 15
Domestic (50 dogs, 29 cats, 1 horse) 80
Unspecified   2
Type of exposure
Bite or contact 72
  with saliva
No contact with saliva 17
Unspecified   8
Treatment payer
Private insurance 39
Medicaid   7
Medicare   3
Patient 14
Other (employer, worker’s   3
  compensation)
Unspecified   6
No reimbursement 25
(N=97)
a x = 28 yrs.
b Health departments in urban areas, as defined by the 1990
census of population for Kentucky. Metropolitan statistical
areas were more likely to administer PEP than rural
departments. (p=.033)
Table 2. Patients receiving postexposure prophylaxis for
exposure to a confirmed rabid animal in Kentucky, 1994
Species Type of exposure Previous history
  of prophylaxis
Bat Bite No
Cata Mucus & Saliva Yesb
Cata Mucus & Saliva No
Cata Cleaned exam table No







Horse Sutured wound Yesb
Skunk Touch No
a Same cat
b Veterinarian with history of preexposure prophylaxis
c Same dog
Total Estimate of State Rabies
Postexposure Prophylaxis
Kentucky sales in 1994 for human diploid cell
vaccine 1.0 ml to nonmilitary providers and
distributors totaled 1,603 doses. The health
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445 were used for PEP in that same year. The
other doses remained as inventory. Assuming
that other users administered human diploid cell
vaccine 1.0 ml in a similar proportion (445/700 =
0.64), the private sector administered 578 doses
(903 x .64) of human diploid cell vaccine 1.0 ml.
Comparing actual local health department use of
human diploid cell vaccine 1.0 ml and estimated
use by others, local health departments admini-
stered 43.5% (445/([445+578]) of the human diploid
cell vaccine 1.0 ml used in the state in 1994.
Therefore, the estimated total number of PEP
patients in the state is 223 (97/.435) for 1994.
Exact total costs for PEP administration can-
not be calculated since most treatments were made
by private providers. The actual cost of biologics
to local health department patients in 1994 was
$68,850. Estimated costs of biologics used by
private providers (based on estimates of hospital
pharmacy costs in Connecticut in 1994) would be
$180,180 for a typical patient (126 patients x
$1,430) (5). Estimated total costs of biologics is
$249,030. Unknown costs include medical and
hospital care, local health department investi-
gation of the incident, state health department con-
sultations, and loss of work income by the patient.
Study Limitations
Because records at the local health
departments were not always complete or as
detailed as desired, certain variables could not be
analyzed for all 97 cases; information about why
the suspect animal was not tested or observed for
rabies was absent from more than 10% of the
cases. Since no detailed information was obtained
from the private sector, we assumed that the
number of doses used per patient, inventory,
waste, spoilage, and other factors influencing
PEP use in the private sector were similar to
those in the public sector. Kentucky residents
receiving PEP in another state and out-of-state
residents receiving PEP in Kentucky would not
be specifically accounted for in our estimate.
The difference in urban versus rural PEP
administration could be due to differences in the
number of animals or bite incidents; however, the
number of animals or animal bites statewide is
not known. An investigation of prescribing
practices of full-time physicians at large, urban
health departments and part-time or contract
physicians at small, rural health departments
might determine if these practices contributed to
treatment disparity.
Guidelines and Noncompliance
Guidelines for determining exposures that
warrant PEP exist (6,7). Ideally, any animal
involved in a human exposure should be confined
and observed or tested for rabies, whichever is
appropriate. It is understandable that most of
the wild animals might have escaped and not be
available for testing. However, the large propor-
tion of domestic animals unavailable for testing
indicates inappropriate handling of the incident
or a breach of existing laws (5-7).
Six people received PEP due to exposure to a
single dog with laboratory-confirmed rabies. This
particular incident illustrates how “anything that
can go wrong will go wrong.” First, the dog had
been vaccinated by the owner. It is illegal for
individual owners to vaccinate their own dogs in
Kentucky (8). Second, the vaccine may have failed
for any number of reasons, including vaccine fail-
ure, improper handling/administration of the
vaccine, or failure to vaccinate. Third, only one of
these patients was bitten; the other five reported
only touching the dog and probably were not
exposed. Fourth, none of these patients had insur-
ance or was able to pay for treatment; thus the
local health departments spent several thousand
dollars in unbudgeted expenses. Furthermore,
four of these patients had received PEP before.
Noncompliance with existing public health
recommendations and laws contributes to the
number of rabies exposure incidents in Kentucky.
PEP administration in Kentucky could be
reduced if existing recommendations and laws
were adhered to by the public and health care
providers. Accurate and complete record keeping
is essential for assessing the use of PEP.  Addi-
tionally, making PEP a notifiable (reportable)
condition would allow public health agencies to
assess PEP administration in the private sector.
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